Jupiter sees continued inflows to institutional arm in Q1 despite retail woes

£1.5bn in market movement

Elliot Gulliver-Needham
clock • 1 min read

Jupiter Fund Management has seen the assets under management of the institutional side of its business increase steadily as the firm experiences continued outflows from its retail, wholesale and investment trusts arms.

In a trading update today (25 April), the firm revealed that AUM had increased by £600m in Q1 to £50.8bn, largely due to positive market movement of £1.5bn. This was supported by £100m in net flows from institutional clients, which was offset by £1bn in outflows from retail, wholesale and investment trusts. Jupiter scraps IA benchmarks from Merlin range Jupiter revealed that it has now seen outflows from its retail, wholesale and investment trusts divisions across the last five quarters, despite market returns picking up over the last two quarters. In contrast, institutional...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot